novo nordisk glp-1 weight loss Eli Lilly set to leapfrog in weight-loss drug race GLP-1 boom lifts Novo Nordisk,
Description
Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels
Follow me (Daniel Carlat, for real-world, clinician-led updates
While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments
Learn more: read our full guide to microdosing tirzepatide and the GLP-1 microdosing chart
Give yourself 10 minutes once a week, and let the rest of the week run on autopilot
An Ohio State dietitian offers advice.
